EW Edwards Lifesciences Corporation Common Stock
$92.49
株価 · 8月 19, 2026
ファンダメンタルズ（時点） 8月 4, 2026
52週レンジ
$72–$96
84% of range
アナリスト評価
BUY
40 analysts
目標株価
$101
+9% upside
P/E (TTM)
57.4
ROE
10.6%
純利益率
17.7%
Edwards Lifesciences Corporation Common Stock について Wikipediaからの企業概要
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.
続きを読む
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.
History
Edwards Lifesciences was originally founded by electrical engineer Miles "Lowell" Edwards in 1958, a graduate of Oregon State University. Edwards invented the first medically proven and adopted artificial heart valve. Dr. Albert Starr, a surgeon at the Oregon Health and Sciences University, is credited as the first to successfully implant the Starr-Edwards mitral valve in a patient in 1960. As a result of the successful heart implant, Edwards established manufacturing in Santa Ana, California the same year to continue his research in pulmonary devices.
Edwards' valves are still in operation today. An early patient lived a record 48 years with the implant before requiring a replacement.
Edwards was acquired by Baxter in 1985. It was spun off from Baxter in 2000.
In 2017, Edwards completed the acquisition of Valtech Cardio for $340 million. Also in 2017, Edwards acquired Harpoon Medical of Baltimore, Maryland for $100 million. Harpoon, founded in 2013, developed a minimally invasive heart surgery product for mitral valve repair to treat degenerative mitral regurgitation. At the time of the acquisition, the product was not available on any market.
On April 18, 2019, Edwards completed the acquisition of CAS Medical Systems of Branford, Connecticut for ~$100 million.
Edwards Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valve systems were FDA-approved for the treatment of patients at low risk for death or major complications associated with open-heart surgery on August 16, 2019. These products are used to treat patients with severe aortic stenosis without utilizing open-heart surgery.
In 2020, Edwards co-sponsored the Virtual ISPOR-FDA Summit centered on patient preference information in medical device regulatory decisions.
In December 2021, the FDA approved the SAPIEN 3 transcatheter valve in combination with the Alterra adaptive prestent for the treatment of severe pulmonary regurgitation.
In February 2024, the FDA approved Edwards' EVOQUE tricuspid valve replacement system, the first transcatheter therapy approved in the United States for the treatment of tricuspid regurgitation. In May 2024, Edwards launched the SAPIEN 3 Ultra RESILIA valve in Europe.
In June 2024, the company received FDA approval for a new implant designed to manage heart failure issues, called the Cordella pulmonary artery sensor.
In July 2024, Edwards made agreements with Affluent Medical for an equity stake, IP licensing and an exclusive option to acquire its Kephalios subsidiary. The same month, Edwards announced it would acquire Innovalve Bio Medical for approximately $300 million, and JenaValve Technology and Endotronix for $1.2 billion.
In August 2024, Edwards acquired JC Medical from Genesis MedTech, gaining its J-Valve transcatheter aortic valve replacement system for the treatment of aortic regurgitation.
In 2023, Edwards announced that its critical care business unit would be spun off into a separate entity. In June 2024 Edwards instead agreed to sell the unit to BD for $4.2 billion. The sale closed on September 3, 2024.
In May 2025, the FDA approved the SAPIEN 3 platform, including the SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA valves, for the treatment of severe aortic stenosis in asymptomatic patients, marking the first FDA approval of TAVR therapy for this patient population.
In September 2025, Edwards completed the full acquisition of heart failure monitoring company Vectorious Medical Technologies.
In January 2026, the FDA approved the SAPIEN M3 mitral valve replacement system, the first transcatheter mitral valve replacement therapy using a transseptal approach to receive FDA approval for the treatment of mitral regurgitation.
Business segments
Prior to September 2024, its products were categorized into four areas: surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and critical care. In September 2024, Edwards completed the sale of its Critical Care product group to BD. Since September 2024, its products are categorized into four areas: surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and implantable heart failure management (IHFM).
Transcatheter Heart Valve
The company's SAPIEN family of transcatheter aortic heart valves is made of bovine pericardial tissue mounted within a balloon-expandable, cobalt-chromium frame and is deployed via catheter. Edwards introduced the transcatheter heart valve replacement procedure to U.S. patients unable to undergo open-heart surgery with FDA approval of the SAPIEN transcatheter valve in 2011. The indication was expanded in November 2012 to include patients at a high risk for death or serious complications associated with open-heart surgery. In 2021, the FDA cleared Edwards’ SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for pulmonic heart valve replacement. In May 2024, Edwards launched the SAPIEN 3 Ultra RESILIA valve in Europe.
Transcatheter Mitral and Tricuspid Therapies
The Transcatheter Mitral and Tricuspid Therapies business segment develops transcatheter heart valve repair and replacement technologies to treat mitral and tricuspid valve diseases. In September 2022, the FDA approved Edwards' PASCAL Precision transcatheter valve repair system for the treatment of degenerative mitral regurgitation.
Surgical
The Surgical business segment involves the use of Edwards' RESILIA tissue technology, developed to help limit valve calcification. Edwards estimates that more than 450,000 patients around the world have either undergone SAVR or TAVR with an Edwards RESILIA valve.
Critical Care
Before its sale, the Critical Care business segment included pulmonary artery catheters, disposable pressure transducers and advanced hemodynamic monitoring systems. The portfolio also included a line of balloon catheter-based vascular products, surgical clips and inserts. In 2023, it was announced that the critical care business unit was to be spun off into its own entity, however in 2024 the critical care department was purchased by BD for $4.2 billion.
Organizational culture
Edwards Lifesciences Foundation
The Edwards Lifesciences Foundation launched in 2014 and supports programs designed to treat underserved people to reduce heart valve disease.
Since the initiative launched in 2014, Edwards and its foundation have contributed more than $100 million in financial and technology donations through "Every Heartbeat Matters" (EHM), reaching over 4 million underserved structural heart patients globally.
出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗
EW 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ
株価
$92.49
時価総額
$61.04B
P/E (TTM)
57.4
EPS（TTM）
$1.83
収益（TTM）
$6.07B
配当利回り
—
ROE
10.6%
負債/自己資本
0.1
52週レンジ
$72 – $96
EW 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ
Configure
10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド
収益と純利益
$6.07B
2016-12-31
→
2025-12-31
EPS
$1.83
2016-12-31
→
2025-12-31
フリーキャッシュフロー
$1.33B
2016-12-31
→
2025-12-31
利益率
17.7%
2016-12-31
→
2025-12-31
バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か？
指標
5年トレンド
EW
競合中央値
P/E (TTM)
57.4
26.3
P/S (TTM) (株価売上高倍率（TTM）)
10.1
4.4
P/B (株価純資産倍率)
5.9
5.3
EV / EBITDA (EV/EBITDA)
40.4
—
Price / FCF (株価FCF倍率)
45.7
—
収益性 粗利益率、営業利益率、純利益率、ROE、ROA、ROIC
指標
5年トレンド
EW
競合中央値
Gross Margin (粗利益率)
78.0%
63.1%
Operating Margin (営業利益率)
20.8%
—
Net Profit Margin (純利益率)
17.7%
15.6%
ROA
8.0%
7.6%
ROE
10.6%
15.0%
ROIC
9.6%
—
財務健全性 負債、流動性、支払能力 — バランスシートの健全性
指標
5年トレンド
EW
競合中央値
Debt / Equity (負債資本倍率)
0.1
—
Current Ratio (流動比率)
3.7
1.7
Quick Ratio (クイックレシオ)
2.7
—
成長 収益、EPS、純利益の成長率：前年比、3年CAGR、5年CAGR
指標
5年トレンド
EW
競合中央値
Revenue YoY (収益（前年比）)
11.6%
—
Revenue CAGR 3Y (収益（3年CAGR）)
10.8%
—
Revenue CAGR 5Y (収益（5年CAGR）)
6.7%
—
EPS YoY
-73.7%
—
Net Income YoY (純利益（前年比）)
-74.3%
—
資本効率 総資産回転率、棚卸資産回転率、売掛金回転率
指標
5年トレンド
EW
競合中央値
EW アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド
買い
40 アナリスト
- 強い買い 13 32.5%
- 買い 17 42.5%
- 保有 10 25.0%
- 売り 0 0.0%
- 強い売り 0 0.0%
12ヶ月目標株価
26 アナリスト · 2026-08-19
中央値
$101.50
現在
$92.49
安値
$84.00
高値
$110.00
中央値ターゲット
$101.50
+9.7%
平均値ターゲット
$100.96
+9.2%
決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日
平均サプライズ
0.02%
| 期間 | EPS Actual | EPS 予想 | サプライズ |
|---|---|---|---|
| 2026年6月30日 | $0.78 | $0.76 | 0.02% |
| 2026年3月31日 | $0.78 | $0.75 | 0.03% |
| 2025年12月31日 | $0.58 | $0.64 | -0.06% |
| 2025年9月30日 | $0.67 | $0.61 | 0.06% |
| 2025年6月30日 | $0.67 | $0.64 | 0.03% |
| 2025年3月31日 | $0.64 | $0.61 | 0.03% |
同業他社比較（GICSサブインダストリー） 主要メトリクスとセクターピアの比較
| ティッカー | 時価総額 | P/E | 売上高 YoY | 純利益率 | ROE | 粗利益率 |
|---|---|---|---|---|---|---|
| EW | $49.50B | 46.6 | 11.6% | 17.7% | 10.6% | 78.0% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | — |
| ISRG | $201.11B | 72.0 | 20.5% | 28.4% | 16.7% | 66.0% |
| SYK | $134.44B | 41.8 | 11.2% | 12.9% | 15.1% | 64.0% |
| BSX | — | 49.1 | 19.9% | 14.4% | 12.6% | 69.0% |
| BDX | — | 25.3 | 8.2% | 7.7% | 6.5% | — |
| IDXX | $53.93B | 51.7 | 10.4% | 24.6% | 69.2% | 61.8% |
| DXCM | $25.54B | 31.8 | 15.6% | 17.9% | 31.4% | 60.1% |
| GEHC | — | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| RMD | $28.11B | 18.7 | 9.8% | 26.9% | 23.6% | 61.1% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | — |
完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー
損益計算書 17
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | |
| Cost of Revenue | $1.33B | $1.12B | $978M | $724M | $1.25B | $1.08B | $1.11B | $939M | $875M | $797M | $617M | $626M | |
| Gross Profit | $4.73B | $4.32B | $4.03B | $3.74B | $3.98B | $3.31B | $3.23B | $2.78B | $2.56B | $2.17B | $1.88B | $1.70B | |
| R&D Expense | $1.08B | $1.05B | $963M | $844M | $903M | $761M | $753M | $622M | $553M | $442M | $383M | $346M | |
| SG&A Expense | $2.09B | $1.79B | $1.58B | $1.36B | $1.49B | $1.23B | $1.24B | $1.09B | $991M | $905M | $851M | $858M | |
| Operating Income | $1.26B | $1.38B | $1.31B | $1.50B | $1.69B | $898M | $1.15B | $748M | $1.09B | $751M | · | · | |
| Interest Expense | · | · | $18M | $19M | $18M | $16M | $21M | $30M | $23M | $19M | $17M | $17M | |
| Interest Income | $169M | $120M | $67M | $36M | $17M | $23M | $32M | $32M | $20M | $11M | $8M | $6M | |
| Other Non-op | $7M | $69M | $14M | $5M | $13M | $12M | $8M | $4M | $-1M | $-5M | $-4M | $-8M | |
| Pretax Income | $1.27B | $1.55B | $1.37B | $1.52B | $1.70B | $917M | $1.17B | $761M | $1.03B | $738M | $622M | $1.14B | |
| Income Tax | $217M | $152M | $152M | $196M | $199M | $93M | $120M | $39M | $451M | $168M | $128M | $333M | |
| Net Income | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | · | · | · | · | · | · | · | |
| EPS (Basic) | $1.84 | $6.98 | $2.31 | $2.46 | $2.41 | $1.32 | $1.68 | $1.15 | $2.77 | $2.67 | $2.30 | $3.81 | |
| EPS (Diluted) | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 | $1.30 | $1.64 | $1.13 | $2.70 | $2.61 | $2.25 | $3.74 | |
| Shares (Basic) | 584,800,000 | 597,700,000 | 606,700,000 | 619,000,000 | 623,300,000 | 622,600,000 | 624,800,000 | 627,600,000 | 210,900,000 | 213,000,000 | 215,500,000 | 213,000,000 | |
| Shares (Diluted) | 585,800,000 | 599,300,000 | 609,400,000 | 624,200,000 | 631,200,000 | 631,900,000 | 636,700,000 | 640,900,000 | 215,900,000 | 217,800,000 | 220,300,000 | 217,000,000 | |
| EBITDA | $1.42B | $1.53B | $1.68B | $1.89B | $1.83B | $1.00B | $1.24B | $826M | $82M | $71M | $66M | $69M |
貸借対照表 29
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.94B | $3.05B | $1.13B | $769M | $863M | $1.18B | $1.18B | $714M | $818M | $930M | $718M | $654M | |
| Short-term Investments | $1.29B | $931M | $500M | $446M | $604M | $219M | $338M | $242M | $519M | $341M | $506M | $785M | |
| Receivables | $660M | $609M | $772M | $643M | $582M | $515M | $544M | $457M | $439M | $366M | $315M | $288M | |
| Inventory | $1.13B | $1.09B | $904M | $876M | $727M | $802M | $641M | $607M | $555M | $397M | $340M | $297M | |
| Prepaid Expense | $135M | $121M | $129M | $110M | $85M | $75M | $59M | $54M | $61M | $46M | $45M | $49M | |
| Other Current Assets | $339M | $348M | $225M | $196M | $237M | $208M | $168M | $132M | $117M | $112M | $66M | $122M | |
| Current Assets | $6.74B | $6.29B | $4.04B | $3.10B | $3.18B | $3.09B | $2.98B | $2.29B | $2.55B | $2.24B | $2.05B | $2.23B | |
| PP&E (Net) | $1.81B | $1.69B | $1.59B | $1.63B | $1.55B | $1.40B | $1.06B | $868M | $680M | $580M | $482M | $443M | |
| PP&E (Gross) | $2.66B | $2.48B | $2.29B | $2.38B | $2.20B | $1.99B | $1.57B | $1.32B | $1.09B | $961M | $854M | $808M | |
| Accum. Depreciation | $850M | $794M | $699M | $750M | $655M | $598M | $512M | $455M | $412M | $381M | $372M | $365M | |
| Goodwill | $1.77B | $1.78B | $1.15B | $1.06B | $1.17B | $1.17B | $1.17B | $1.11B | $1.13B | $626M | $628M | $376M | |
| Intangibles | $1.13B | $1.18B | $399M | $285M | $324M | $331M | $336M | $343M | $468M | $205M | $205M | $23M | |
| Other Non-current Assets | $730M | $722M | $463M | $299M | $111M | $120M | $102M | $34M | $109M | $123M | $132M | $49M | |
| Total Assets | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B | $6.49B | $5.32B | $5.67B | $4.51B | $4.06B | $3.52B | |
| Accounts Payable | $228M | $197M | $187M | $202M | $204M | $196M | $180M | $134M | $117M | $97M | $64M | $58M | |
| Current Liabilities | $1.81B | $1.51B | $1.20B | $1.02B | $1.03B | $894M | $902M | $877M | $1.42B | $532M | $476M | $426M | |
| Capital Leases | $83M | $79M | $65M | $70M | $69M | $73M | $59M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | $37M | · | · | · | · | · | |
| Other Non-current Liabilities | $362M | $373M | $251M | $218M | $267M | $252M | $203M | $150M | $147M | $115M | $285M | $113M | |
| Total Liabilities | $3.36B | $2.99B | $2.64B | $2.49B | $2.67B | $2.66B | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | $594M | $1.04B | $822M | · | · | |
| Total Debt | $598M | $598M | $597M | $596M | $596M | $595M | $594M | $594M | $1.04B | $822M | $600M | $598M | |
| Common Stock | $659M | $655M | $650M | $646M | $642M | $636M | $218M | $215M | $212M | $243M | $239M | $129M | |
| Retained Earnings | $14.24B | $13.17B | $8.99B | $7.59B | $6.07B | $4.57B | $3.74B | $2.69B | $1.96B | $3.91B | $3.34B | $2.84B | |
| Treasury Stock | $7.09B | $6.19B | $5.02B | $4.14B | $2.42B | $1.90B | $1.28B | $1.02B | $252M | $2.50B | $1.84B | $1.56B | |
| AOCI | $-238M | $-244M | $-243M | $-255M | $-158M | $-161M | $-156M | $-138M | $-133M | $-198M | $-183M | $-101M | |
| Stockholders' Equity | $10.34B | $10.00B | $6.65B | $5.81B | $5.84B | $4.57B | $4.15B | $3.14B | $2.96B | $2.62B | $2.50B | $2.19B | |
| Liabilities + Equity | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B | $6.49B | $5.32B | $5.67B | $4.51B | $4.06B | $3.52B | |
| Shares Outstanding | 580,700,000 | 654,800,000 | 650,500,000 | 646,300,000 | 642,000,000 | 636,400,000 | 218,100,000 | 207,700,000 | 209,700,000 | 211,600,000 | 215,400,000 | 107,800,000 |
キャッシュフロー 18
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $157M | $155M | $145M | $140M | $135M | $107M | $89M | $77M | $82M | $71M | $66M | $69M | |
| Stock-based Comp | $158M | $162M | $139M | $127M | $109M | $93M | $81M | $71M | $62M | $57M | $50M | $48M | |
| Deferred Tax | $-66M | $-163M | $-242M | $-262M | $-44M | $-52M | $10M | $-21M | $27M | $-24M | $-16M | $-67M | |
| Amort. of Intangibles | $8M | $6M | $2M | $2M | $8M | $5M | $5M | $2M | $8M | $8M | $7M | $8M | |
| Restructuring | $13M | $33M | · | · | · | · | · | · | · | · | $0 | $0 | |
| Other Non-cash | $273M | $-3.79B | $-529M | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $1.60B | $542M | $896M | $1.22B | $1.73B | $1.05B | $1.18B | $927M | $1.00B | $704M | $550M | $1.02B | |
| CapEx | $260M | $252M | $253M | $245M | $326M | $407M | $254M | $239M | $168M | $176M | $103M | $83M | |
| Investing Cash Flow | $-713M | $2.31B | $174M | $252M | $-1.72B | $-531M | $-596M | $77M | $-647M | $-212M | $-316M | · | |
| Debt Issued | · | · | $0 | $0 | $5M | $16M | $19M | $688M | $995M | $254M | $31M | $226M | |
| Net Debt Issued | · | · | $0 | $0 | $5M | $16M | $19M | $688M | $995M | $254M | $31M | $226M | |
| Stock Repurchased | $893M | $1.16B | $880M | $1.73B | $513M | $625M | $263M | $796M | $763M | $662M | $280M | $301M | |
| Net Stock Activity | $-893M | $-1.16B | $-880M | $-1.73B | $-513M | $-625M | $-263M | $-796M | $-763M | $-662M | $-280M | $-301M | |
| Financing Cash Flow | $-957M | $-983M | $-711M | $-1.58B | $-356M | $-487M | $-116M | $-1.10B | $-473M | $-268M | $-159M | · | |
| Net Change in Cash | $-119M | $1.91B | $375M | $-95M | $-333M | $16M | $468M | $-104M | $-112M | $212M | $65M | $233M | |
| Taxes Paid | $490M | $1.20B | $470M | · | · | · | · | · | · | · | · | $275M | |
| Free Cash Flow | $1.33B | $290M | $643M | $974M | $1.41B | $647M | $925M | $688M | $833M | $528M | $447M | $939M | |
| Levered FCF | · | · | $627M | $957M | $1.39B | $633M | $906M | $660M | $820M | $513M | $433M | $927M |
収益性 8
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 78.0% | 79.5% | 77.0% | 79.9% | 76.1% | 75.4% | 74.4% | 74.8% | 74.5% | 73.1% | 75.2% | 73.1% | |
| Operating Margin | 20.8% | 25.4% | 25.6% | 32.5% | 32.3% | 20.5% | 26.4% | 20.1% | · | · | · | · | |
| Net Margin | 17.7% | 76.8% | 23.4% | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | 21.0% | 28.5% | 26.6% | 32.8% | 32.5% | 20.9% | 26.8% | 20.4% | 30.1% | 24.9% | 25.0% | 49.2% | |
| EBITDA Margin | 23.4% | 28.2% | 28.0% | 35.1% | 34.9% | 22.9% | 28.4% | 22.2% | 2.4% | 2.4% | 2.6% | 2.9% | |
| ROA | 8.0% | 37.2% | 15.9% | · | · | · | · | · | · | · | · | · | |
| ROE | 10.6% | 50.1% | 22.5% | · | · | · | · | · | · | · | · | · | |
| ROIC | 9.6% | 11.7% | 18.5% | 23.5% | 23.2% | 15.6% | 21.7% | 19.0% | · | · | · | · |
流動性と支払能力 5
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.7 | 4.2 | 3.4 | 3.0 | 3.1 | 3.5 | 3.3 | 2.6 | 1.8 | 4.2 | 4.3 | 5.3 | |
| Quick Ratio | 2.7 | 3.0 | 2.0 | 1.8 | 2.0 | 2.1 | 2.3 | 1.6 | 1.3 | 3.1 | 3.2 | 4.0 | |
| Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.4 | 0.3 | 0.2 | 0.3 | |
| LT Debt / Equity | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.3 | 0.2 | 0.3 | |
| Interest Coverage | · | · | 87.2 | 91.1 | 91.9 | 56.8 | 55.4 | 25.0 | · | · | · | · |
効率性 3
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.7 | 0.6 | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Inventory Turnover | 1.2 | 1.1 | 1.4 | 1.3 | 1.6 | 1.5 | 1.8 | 1.6 | 1.8 | 2.2 | 1.9 | 2.1 | |
| Receivables Turnover | 9.6 | 7.9 | 8.5 | 8.8 | 9.5 | 8.3 | 8.7 | 8.3 | 8.7 | 8.7 | 8.3 | 7.9 |
成長率 8
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.6% | 8.6% | 12.2% | -14.7% | 19.3% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 10.8% | 1.3% | 4.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -73.7% | 203.0% | -5.7% | 2.5% | 83.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -9.1% | 43.1% | 20.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -74.3% | 197.7% | -7.8% | 1.2% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -11.0% | 40.6% | · | · | · | · | · | · | · | · | · | · |
バリュエーション（TTM） 14
| 指標 | トレンド | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B | $4.35B | $3.72B | $3.44B | $2.96B | $2.49B | $2.32B | |
| Net Income TTM | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | $235M | $235M | $235M | $235M | $235M | $235M | $235M | |
| Market Cap | $49.50B | $43.57B | $45.83B | $45.39B | $80.85B | $56.95B | $16.26B | $10.60B | $7.88B | $6.61B | $5.67B | $2.29B | |
| Enterprise Value | $45.88B | $40.20B | $44.79B | $44.77B | $79.98B | $56.15B | $15.34B | $10.24B | $7.58B | $6.16B | $5.05B | $1.45B | |
| P/E | 46.6 | 10.6 | 33.2 | 30.6 | 54.4 | 70.2 | 47.4 | 45.2 | 13.9 | 12.0 | 11.7 | 5.7 | |
| P/S | 8.2 | 8.0 | 9.1 | 10.2 | 15.5 | 13.0 | 3.7 | 2.8 | 2.3 | 2.2 | 2.3 | 1.0 | |
| P/B | 4.8 | 4.4 | 6.9 | 7.8 | 13.9 | 12.5 | 3.9 | 3.4 | 2.7 | 2.5 | 2.3 | 1.0 | |
| P / Tangible Book | 6.7 | 6.2 | 9.0 | 10.2 | 18.6 | 18.6 | · | · | · | · | · | · | |
| P / Cash Flow | 31.0 | 80.4 | 51.2 | 37.3 | 46.7 | 54.0 | 13.8 | 11.4 | 7.9 | 9.4 | 10.3 | 2.2 | |
| P / FCF | 37.1 | 150.3 | 71.3 | 46.6 | 57.5 | 88.0 | 17.6 | 15.4 | 9.5 | 12.5 | 12.7 | 2.4 | |
| EV / EBITDA | 32.3 | 26.2 | 26.7 | 23.7 | 43.8 | 55.9 | 12.4 | 12.4 | 92.5 | 86.5 | 76.7 | 21.1 | |
| EV / FCF | 34.4 | 138.7 | 69.7 | 46.0 | 56.9 | 86.7 | 16.6 | 14.9 | 9.1 | 11.7 | 11.3 | 1.5 | |
| EV / Revenue | 7.6 | 7.4 | 8.9 | 10.0 | 15.3 | 12.8 | 3.5 | 2.8 | 2.2 | 2.1 | 2.0 | 0.6 | |
| Earnings Yield | 2.1% | 9.4% | 3.0% | 3.3% | 1.8% | 1.4% | 2.1% | 2.2% | 7.2% | 8.4% | 8.6% | 17.6% |
損益計算書 16
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.74B | $1.65B | $1.57B | $1.55B | $1.53B | $1.41B | $1.39B | $1.35B | $1.37B | $1.33B | $1.01B | $1.24B | $1.28B | $1.22B | $430M | $1.32B | |
| Cost of Revenue | $392M | $363M | $343M | $345M | $344M | $302M | $292M | $263M | $276M | $287M | $141M | $251M | $257M | $330M | $-99M | $254M | |
| Gross Profit | $1.35B | $1.29B | $1.23B | $1.21B | $1.19B | $1.11B | $1.09B | $1.09B | $1.09B | $1.04B | $870M | $993M | $1.03B | $992M | $529M | $1.07B | |
| R&D Expense | $279M | $263M | $268M | $281M | $276M | $255M | $271M | $253M | $272M | $257M | $215M | $243M | $244M | $261M | $131M | $234M | |
| SG&A Expense | $561M | $522M | $603M | $515M | $502M | $466M | $492M | $421M | $448M | $428M | $354M | $382M | $410M | $436M | $201M | $377M | |
| Operating Income | $513M | $478M | $151M | $307M | $411M | $395M | $313M | $351M | $366M | $349M | $291M | $366M | $264M | $388M | $198M | $402M | |
| Interest Income | $30M | $34M | · | · | $37M | $36M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $17M | $72M | $3M | $3M | $-1M | $3M | $33M | $28M | $2M | $6M | $3M | $7M | $2M | $2M | $6M | $-2M | |
| Pretax Income | $520M | $459M | $90M | $348M | $400M | $434M | $390M | $403M | $384M | $371M | $311M | $388M | $275M | $399M | $211M | $407M | |
| Income Tax | $278M | $78M | $26M | $56M | $64M | $70M | $45M | $41M | $20M | $46M | $21M | $53M | $21M | $58M | $11M | $64M | |
| Net Income | $242M | $381M | $91M | $291M | $333M | $358M | $386M | $3.07B | $366M | $352M | $370M | $385M | $307M | $340M | $398M | $344M | |
| EPS (Basic) | $0.42 | $0.66 | $0.16 | $0.50 | $0.57 | $0.61 | $0.65 | $5.14 | $0.61 | $0.58 | $0.61 | $0.63 | $0.51 | $0.56 | $0.66 | $0.55 | |
| EPS (Diluted) | $0.42 | $0.66 | $0.16 | $0.50 | $0.56 | $0.61 | $0.65 | $5.13 | $0.61 | $0.58 | $0.61 | $0.63 | $0.50 | $0.56 | $0.65 | $0.55 | |
| Shares (Basic) | 576,400,000 | 579,200,000 | -1,173,800,000 | 584,700,000 | 587,000,000 | 586,900,000 | -1,203,200,000 | 597,200,000 | 602,100,000 | 601,600,000 | -1,214,700,000 | 607,000,000 | 606,900,000 | 607,500,000 | -1,243,800,000 | 619,800,000 | |
| Shares (Diluted) | 577,600,000 | 580,700,000 | -1,175,600,000 | 585,700,000 | 587,900,000 | 587,800,000 | -1,207,200,000 | 598,100,000 | 604,300,000 | 604,100,000 | -1,221,300,000 | 609,500,000 | 610,300,000 | 610,900,000 | -1,256,400,000 | 624,500,000 | |
| EBITDA | $513M | $518M | · | $307M | $411M | $431M | · | $351M | $369M | $426M | · | $418M | $327M | $424M | · | $402M |
貸借対照表 27
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.91B | $2.45B | $2.94B | $2.69B | $3.27B | $3.14B | $3.05B | $3.68B | $1.64B | $1.22B | · | $1.41B | $1.04B | $872M | · | $1.25B | |
| Short-term Investments | $1.35B | $1.23B | $1.29B | $1.16B | $789M | $758M | $931M | $770M | $345M | $473M | · | $454M | $467M | $382M | · | $491M | |
| Receivables | $770M | $776M | $660M | $693M | $697M | $669M | $609M | $716M | $778M | $818M | · | $740M | $754M | $718M | · | $618M | |
| Inventory | $1.13B | $1.12B | $1.13B | $1.14B | $1.14B | $1.11B | $1.09B | $1.10B | $1.02B | $1.21B | · | $1.03B | $980M | $914M | · | $758M | |
| Prepaid Expense | $119M | $136M | $135M | $125M | $110M | $111M | $121M | $115M | $110M | $138M | · | $133M | $123M | $119M | · | $88M | |
| Other Current Assets | $360M | $330M | $339M | $323M | $314M | $304M | $348M | $231M | $252M | $251M | · | $236M | $217M | $190M | · | $268M | |
| Current Assets | $6.82B | $6.23B | $6.74B | $6.36B | $6.58B | $6.21B | $6.29B | $6.73B | $4.52B | $4.17B | · | $4.07B | $3.65B | $3.26B | · | $3.51B | |
| PP&E (Net) | $1.84B | $1.82B | $1.81B | $1.74B | $1.73B | $1.70B | $1.69B | $1.68B | $1.64B | $1.77B | · | $1.68B | $1.66B | $1.65B | · | $1.57B | |
| PP&E (Gross) | · | · | $2.66B | · | · | · | $2.48B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $850M | · | · | · | $794M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $1.95B | $1.82B | $1.77B | $1.77B | $1.78B | $1.78B | $1.78B | $1.61B | $1.15B | $1.25B | $1.15B | $1.30B | $1.30B | $1.31B | $1.06B | $1.16B | |
| Intangibles | $1.38B | $1.23B | $1.13B | $1.13B | $1.17B | $1.17B | $1.18B | $956M | $417M | $447M | · | $430M | $431M | $447M | · | $266M | |
| Other Non-current Assets | $616M | $739M | $730M | $785M | $743M | $743M | $722M | $684M | $790M | $768M | · | $447M | $412M | $294M | · | $316M | |
| Total Assets | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B | $9.74B | · | $9.37B | $9.00B | $8.65B | · | $8.64B | |
| Accounts Payable | $210M | $181M | $228M | $165M | $162M | $172M | $197M | $173M | $186M | $212M | · | $191M | $193M | $181M | · | $155M | |
| Current Liabilities | $1.51B | $1.41B | $1.81B | $1.59B | $1.40B | $1.39B | $1.51B | $1.94B | $1.22B | $1.11B | · | $1.24B | $1.16B | $1.08B | · | $918M | |
| Capital Leases | $82M | $80M | $83M | $75M | $79M | $78M | $79M | $85M | $74M | $77M | · | $70M | $64M | $66M | · | $67M | |
| Other Non-current Liabilities | $382M | $351M | $362M | $363M | $379M | $358M | $373M | $323M | $257M | $266M | · | $240M | $243M | $260M | · | $221M | |
| Total Liabilities | $3.14B | $2.99B | $3.36B | $3.07B | $2.88B | $2.83B | $2.99B | $3.36B | $2.59B | $2.55B | · | $2.64B | $2.56B | $2.59B | · | $2.42B | |
| Total Debt | $599M | $598M | · | $598M | $598M | $598M | · | $598M | $597M | $597M | · | $597M | $597M | $596M | · | $596M | |
| Common Stock | $662M | $660M | $659M | $658M | $658M | $656M | $655M | $654M | $654M | $652M | · | $650M | $649M | $647M | · | $646M | |
| Retained Earnings | $14.86B | $14.62B | $14.24B | $14.15B | $13.86B | $13.53B | $13.17B | $12.78B | $9.71B | $9.34B | · | $8.62B | $8.24B | $7.93B | · | $7.19B | |
| Treasury Stock | $7.67B | $7.51B | $7.09B | $7.05B | $6.46B | $6.45B | $6.19B | $6.09B | $5.18B | $5.02B | · | $4.58B | $4.40B | $4.39B | · | $3.28B | |
| AOCI | $-215M | $-221M | $-238M | $-250M | $-264M | $-254M | $-244M | $-252M | $-220M | $-233M | · | $-250M | $-256M | $-255M | · | $-256M | |
| Stockholders' Equity | $10.62B | $10.33B | $10.34B | $10.21B | $10.55B | $10.13B | $10.00B | $9.55B | $7.44B | $7.12B | · | $6.66B | $6.38B | $5.98B | · | $6.22B | |
| Liabilities + Equity | $13.87B | $13.32B | $13.70B | $13.27B | $13.49B | $13.02B | $13.06B | $12.97B | $10.10B | $9.74B | · | $9.37B | $9.00B | $8.65B | · | $8.64B | |
| Shares Outstanding | 576,600,000 | 577,000,000 | 580,700,000 | 580,700,000 | 587,900,000 | 586,200,000 | 588,600,000 | 589,800,000 | 602,300,000 | 602,400,000 | 650,500,000 | 606,500,000 | 607,900,000 | 606,000,000 | 646,300,000 | 619,400,000 |
キャッシュフロー 13
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $43M | $41M | $43M | $39M | $38M | $37M | $43M | $34M | $40M | $38M | $37M | $37M | $36M | $35M | $35M | $35M | |
| Stock-based Comp | $42M | $45M | $39M | $41M | $38M | $40M | $32M | $42M | $44M | $45M | $30M | $33M | $37M | $39M | $28M | $30M | |
| Restructuring | · | · | $5M | $100.0K | · | · | $0 | $33M | · | · | · | $0 | · | · | · | · | |
| Other Non-cash | · | $-423M | · | · | · | $-154M | · | · | · | $-488M | · | · | · | · | · | · | |
| Operating Cash Flow | $652M | $44M | $451M | $574M | $290M | $280M | $-128M | $352M | $372M | $-54M | $137M | $412M | $34M | $314M | $283M | $310M | |
| CapEx | $67M | $65M | $97M | $58M | $49M | $56M | $50M | $52M | $85M | $65M | $88M | $55M | $48M | $62M | $69M | $60M | |
| Investing Cash Flow | $-193M | $-93M | $-198M | $-428M | $-172M | $85M | $-577M | $2.70B | $125M | $63M | $14M | $89M | $70M | $500.0K | $95M | $-202M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $153M | $422M | $41M | $589M | $6M | $259M | $100M | $901M | $158M | $200.0K | $448M | $174M | $8M | $249M | $866M | $100M | |
| Net Stock Activity | · | $-422M | · | · | · | $-259M | · | · | · | $-200.0K | · | · | · | $-249M | · | · | |
| Financing Cash Flow | $-300.0K | $-451M | $-11M | $-740M | $53M | $-258M | $29M | $-977M | $-97M | $62M | $-413M | $-143M | $52M | $-207M | $-838M | $-70M | |
| Net Change in Cash | $462M | $-492M | $245M | $-595M | $141M | $90M | $-625M | $2.03B | $429M | $81M | $-266M | $366M | $171M | $104M | $-479M | $49M | |
| Free Cash Flow | · | $-21M | · | · | · | $224M | · | · | · | $-119M | · | · | · | $253M | · | · |
収益性 8
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 77.5% | 78.0% | · | 77.8% | 77.5% | 78.6% | · | 80.6% | 79.4% | 75.9% | · | 76.3% | 77.6% | 77.4% | · | 80.8% | |
| Operating Margin | 29.5% | 29.0% | · | 19.8% | 26.8% | 28.0% | · | 25.9% | 26.6% | 24.2% | · | 28.2% | 21.4% | 26.6% | · | 30.5% | |
| Net Margin | 13.9% | 23.1% | · | 18.7% | 21.8% | 25.3% | · | 226.7% | 26.4% | 22.0% | · | 26.0% | 20.1% | · | · | · | |
| Pretax Margin | 29.9% | 27.8% | · | 22.4% | 26.1% | 30.7% | · | 29.7% | 27.9% | 25.6% | · | 29.7% | 22.1% | 27.3% | · | 30.9% | |
| EBITDA Margin | 29.5% | 31.4% | · | 19.8% | 26.8% | 30.5% | · | 25.9% | 26.6% | 26.7% | · | 28.2% | 21.4% | 29.0% | · | 30.5% | |
| ROA | 1.8% | 2.9% | · | 2.2% | 2.8% | 3.1% | · | 27.5% | 3.8% | 3.8% | · | 4.3% | 3.5% | · | · | · | |
| ROE | 2.3% | 3.7% | · | 2.9% | 3.7% | 4.2% | · | 37.9% | 5.3% | 5.4% | · | 6.0% | 5.0% | · | · | · | |
| ROIC | 2.1% | 3.6% | · | 2.4% | 3.1% | 3.1% | · | 3.1% | 4.3% | 4.3% | · | 5.0% | 4.2% | 5.1% | · | 5.0% |
流動性と支払能力 4
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.4 | · | 4.0 | 4.7 | 4.5 | · | 3.5 | 3.7 | 3.8 | · | 3.3 | 3.2 | 3.0 | · | 3.8 | |
| Quick Ratio | 3.3 | 3.2 | · | 2.9 | 3.4 | 3.3 | · | 2.7 | 2.3 | 2.3 | · | 2.1 | 2.0 | 1.8 | · | 2.6 | |
| Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 |
効率性 3
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | |
| Receivables Turnover | 2.4 | 2.3 | · | 2.2 | 2.1 | 1.9 | · | 1.9 | 1.8 | 2.1 | · | 2.2 | 2.2 | 2.2 | · | 2.2 |
バリュエーション（TTM） 14
| 指標 | トレンド | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.47B | $6.15B | · | $5.88B | $5.69B | $5.52B | · | $5.32B | $5.21B | $5.12B | · | $5.06B | $5.19B | $5.26B | · | $5.34B | |
| Net Income TTM | $1.25B | $1.36B | · | $1.37B | $4.15B | $4.18B | · | $4.16B | $1.47B | $1.41B | · | $1.38B | $1.40B | · | · | · | |
| Market Cap | $52.16B | $46.21B | · | $45.16B | $45.98B | $42.49B | · | $38.92B | $55.63B | $57.57B | · | $42.02B | $57.34B | $50.13B | · | $51.18B | |
| Enterprise Value | $48.51B | $43.13B | · | $41.92B | $42.52B | $39.19B | · | $35.07B | $54.24B | $56.46B | · | $40.75B | $56.43B | $49.48B | · | $50.04B | |
| P/E | 42.3 | 34.4 | · | 33.5 | 11.3 | 10.4 | · | 9.5 | 38.0 | 41.2 | · | 30.9 | 41.7 | 35.2 | · | 35.5 | |
| P/S | 8.1 | 7.5 | · | 7.7 | 8.1 | 7.7 | · | 7.3 | 10.7 | 11.2 | · | 8.3 | 11.0 | 9.5 | · | 9.6 | |
| P/B | 4.9 | 4.5 | · | 4.4 | 4.4 | 4.2 | · | 4.1 | 7.5 | 8.1 | · | 6.3 | 9.0 | 8.4 | · | 8.2 | |
| P / Tangible Book | 7.2 | 6.3 | · | 6.2 | 6.1 | 5.9 | · | 5.6 | 9.5 | 10.6 | · | 8.5 | 12.3 | 11.9 | · | 10.7 | |
| P / Cash Flow | · | 1054.9 | · | · | · | 151.5 | · | · | · | -1076.0 | · | · | · | 159.6 | · | · | |
| P / FCF | · | -2189.9 | · | · | · | 189.3 | · | · | · | -484.6 | · | · | · | 198.5 | · | · | |
| EV / EBITDA | 94.5 | 83.2 | · | 136.5 | 103.4 | 90.8 | · | 100.0 | 147.0 | 132.5 | · | 97.4 | 172.5 | 116.8 | · | 124.4 | |
| EV / FCF | · | -2044.2 | · | · | · | 174.6 | · | · | · | -475.3 | · | · | · | 195.9 | · | · | |
| EV / Revenue | 7.5 | 7.0 | · | 7.1 | 7.5 | 7.1 | · | 6.6 | 10.4 | 11.0 | · | 8.0 | 10.9 | 9.4 | · | 9.4 | |
| Earnings Yield | 2.4% | 2.9% | · | 3.0% | 8.9% | 9.7% | · | 10.5% | 2.6% | 2.4% | · | 3.2% | 2.4% | 2.8% | · | 2.8% |
財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間
損益計算書
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 収益 | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B |
| 粗利益率 % | 78.0% | 79.5% | 77.0% | 79.9% | 76.1% |
| 営業利益率 % | 20.8% | 25.4% | 25.6% | 32.5% | 32.3% |
| 純利益 | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B |
| 希薄化後EPS | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 |
貸借対照表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 負債資本倍率 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| 流動比率 | 3.7 | 4.2 | 3.4 | 3.0 | 3.1 |
| クイックレシオ | 2.7 | 3.0 | 2.0 | 1.8 | 2.0 |
キャッシュフロー
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| フリーキャッシュフロー | $1.33B | $290M | $643M | $974M | $1.41B |
マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行
📊
あなたにとって重要なメトリクスを選択 — 上記の決算詳細の任意の行の横にある➕をクリックしてください。
選択内容は保存され、すべてのティッカーで引き継がれます。
機関投資家（13F） 1,442 提出者 · $30.2B合計 · 時点 2026年6月30日
四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。
機関投資家の動向 — Q2 2026 対 前四半期
| 新規ポジション | 解消済みポジション | 増加 | 減少 | 純株式数増減 |
|---|---|---|---|---|
| 152 (+6 前期比) | 97 (-10 前期比) | 459 (+11 前期比) | 452 (+4 前期比) | +26.4M |
Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。
| 機関投資家 | 評価額 | 株式数 | % 追跡された13Fのうち | タイプ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $3,402,739,018 | 37,615,952 | 11.25% | 株式数 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,389,175,425 | 26,411,402 | 7.90% | 株式数 |
| STATE STREET CORP | $2,381,082,692 | 26,321,940 | 7.87% | 株式数 |
| WELLINGTON MANAGEMENT GROUP LLP | $1,430,999,585 | 15,819,142 | 4.73% | 株式数 |
| GEODE CAPITAL MANAGEMENT, LLC | $1,219,437,867 | 13,541,730 | 4.03% | 株式数 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $1,135,640,991 | 12,554,068 | 3.75% | 株式数 |
| Ninety One UK Ltd | $1,116,050,276 | 12,337,502 | 3.69% | 株式数 |
| Aristotle Capital Management, LLC | $783,906,442 | 8,665,712 | 2.59% | 株式数 |
| NORGES BANK | $757,492,410 | 8,373,783 | 2.50% | 株式数 |
| ALLIANCEBERNSTEIN L.P. | $693,526,113 | 8,660,416 | 2.29% | 株式数 |
| FMR LLC | $607,177,379 | 6,712,109 | 2.01% | 株式数 |
| Artisan Partners Limited Partnership | $599,361,052 | 6,625,703 | 1.98% | 株式数 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $513,572,538 | 5,677,344 | 1.70% | 株式数 |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | $434,208,000 | 4,800,000 | 1.44% | 株式数 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $334,052,859 | 3,692,824 | 1.10% | 株式数 |
| MILLENNIUM MANAGEMENT LLC | $324,280,556 | 3,584,795 | 1.07% | 株式数 |
| CITADEL ADVISORS LLC | $308,338,066 | 3,408,557 | 1.02% | 株式数 |
| PRIMECAP MANAGEMENT CO/CA/ | $308,314,004 | 3,408,291 | 1.02% | 株式数 |
| DIMENSIONAL FUND ADVISORS LP | $298,865,427 | 3,303,843 | 0.99% | 株式数 |
| BROWN ADVISORY INC | $295,062,880 | 3,261,805 | 0.98% | 株式数 |
| VANGUARD FIDUCIARY TRUST CO | $292,399,738 | 3,232,365 | 0.97% | 株式数 |
| Holocene Advisors, LP | $283,979,721 | 3,139,285 | 0.94% | 株式数 |
| NEUBERGER BERMAN GROUP LLC | $255,069,412 | 2,818,763 | 0.84% | 株式数 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $250,776,107 | 2,772,232 | 0.83% | 株式数 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $238,277,000 | 2,634,054 | 0.79% | 株式数 |
| Mirova US LLC | $229,802,865 | 2,540,381 | 0.76% | 株式数 |
| BANK OF AMERICA CORP /DE/ | $170,884,489 | 1,889,061 | 0.56% | 株式数 |
| BlackRock, Inc. | $168,018,323 | 1,857,377 | 0.56% | 株式数 |
| Assenagon Asset Management S.A. | $163,997,286 | 1,812,926 | 0.54% | 株式数 |
| Point72 Asset Management, L.P. | $160,486,895 | 1,774,120 | 0.53% | 株式数 |
| RAYMOND JAMES FINANCIAL INC | $152,806,000 | 1,689,211 | 0.51% | 株式数 |
| Swiss National Bank | $147,097,006 | 1,626,100 | 0.49% | 株式数 |
| Woodline Partners LP | $141,123,209 | 1,560,062 | 0.47% | 株式数 |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $140,351,128 | 1,551,434 | 0.46% | 株式数 |
| TWO SIGMA INVESTMENTS, LP | $137,670,984 | 1,521,899 | 0.46% | 株式数 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $131,472,173 | 1,453,357 | 0.43% | 株式数 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $126,120,870 | 1,394,217 | 0.42% | 株式数 |
| Legal & General Group Plc | $121,108,845 | 1,338,811 | 0.40% | 株式数 |
| ROYAL BANK OF CANADA | $119,193,000 | 1,317,637 | 0.39% | 株式数 |
| Sumitomo Mitsui Trust Group, Inc. | $113,885,341 | 1,258,958 | 0.38% | 株式数 |
| Quantinno Capital Management LP | $113,292,795 | 1,252,407 | 0.37% | 株式数 |
| Vanguard Global Advisers, LLC | $112,247,472 | 1,240,852 | 0.37% | 株式数 |
| VANGUARD GROUP INC | $107,656,172 | 1,262,829 | 0.36% | 株式数 |
| SEB Asset Management AB | $106,981,085 | 1,182,636 | 0.35% | 株式数 |
| Liontrust Investment Partners LLP | $106,083,480 | 1,244,381 | 0.35% | 株式数 |
| VANGUARD ASSET MANAGEMENT, Ltd | $100,522,409 | 1,111,236 | 0.33% | 株式数 |
| Polar Capital Holdings Plc | $99,945,636 | 1,104,860 | 0.33% | 株式数 |
| RHUMBLINE ADVISERS | $99,213,696 | 1,096,770 | 0.33% | 株式数 |
| BNP PARIBAS FINANCIAL MARKETS | $92,822,996 | 1,026,122 | 0.31% | 株式数 |
| PARNASSUS INVESTMENTS, LLC | $91,873,890 | 1,015,630 | 0.30% | 株式数 |
| Bank of New York Mellon Corp | $91,654,072 | 1,013,200 | 0.30% | 株式数 |
| National Pension Service | $90,349,187 | 998,775 | 0.30% | 株式数 |
| California Public Employees Retirement System | $89,091,250 | 984,869 | 0.29% | 株式数 |
| Caisse de depot et placement du Quebec | $87,523,397 | 967,537 | 0.29% | 株式数 |
| ABN AMRO Bank N.V. | $83,573,385 | 924,314 | 0.28% | 株式数 |
| GOLDMAN SACHS GROUP INC | $82,454,109 | 911,498 | 0.27% | 株式数 |
| Empower Advisory Group, LLC | $80,384,543 | 888,620 | 0.27% | 株式数 |
| Meridiem Capital Partners LP | $77,697,994 | 858,921 | 0.26% | 株式数 |
| Man Group plc | $76,372,212 | 844,265 | 0.25% | 株式数 |
| ORBIMED ADVISORS LLC | $75,525,054 | 834,900 | 0.25% | 株式数 |
| Alyeska Investment Group, L.P. | $73,531,316 | 812,860 | 0.24% | 株式数 |
| Nantahala Capital Management, LLC | $72,368,000 | 800,000 | 0.24% | プットオプション |
| CANADA PENSION PLAN INVESTMENT BOARD | $72,254,020 | 798,740 | 0.24% | 株式数 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $69,805,736 | 871,700 | 0.23% | 株式数 |
| ENVESTNET ASSET MANAGEMENT INC | $66,940,606 | 740,002 | 0.22% | 株式数 |
| Bellevue Group AG | $66,871,108 | 739,234 | 0.22% | 株式数 |
| Birch Hill Investment Advisors LLC | $66,522,203 | 735,377 | 0.22% | 株式数 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $64,772,074 | 716,030 | 0.21% | 株式数 |
| TD Asset Management Inc | $61,560,472 | 680,527 | 0.20% | 株式数 |
| PRINCIPAL FINANCIAL GROUP INC | $61,491,904 | 679,769 | 0.20% | 株式数 |
| UBS Group AG | $60,908,889 | 673,324 | 0.20% | 株式数 |
| Candriam S.C.A. | $59,988,129 | 663,784 | 0.20% | 株式数 |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $57,604,363 | 675,711 | 0.19% | 株式数 |
| Integral Health Asset Management, LLC | $56,537,500 | 625,000 | 0.19% | 株式数 |
| Ninety One North America, Inc. | $55,768,413 | 616,498 | 0.18% | 株式数 |
| Robeco Institutional Asset Management B.V. | $55,270,246 | 610,991 | 0.18% | 株式数 |
| Seilern Investment Management Ltd | $54,296,896 | 600,231 | 0.18% | 株式数 |
| Nan Shan Life Insurance Co., Ltd. | $49,953,912 | 552,221 | 0.17% | 株式数 |
| PFA Pension, Forsikringsaktieselskab | $49,175,025 | 543,611 | 0.16% | 株式数 |
| BARCLAYS PLC | $49,135,520 | 543,174 | 0.16% | 株式数 |
| Triodos Investment Management BV | $44,629,165 | 493,358 | 0.15% | 株式数 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $44,266,149 | 489,345 | 0.15% | 株式数 |
| Mitsubishi UFJ Trust & Banking Corp | $43,182,890 | 477,370 | 0.14% | 株式数 |
| APG Asset Management N.V. | $42,840,046 | 541,444 | 0.14% | 株式数 |
| United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund | $42,480,287 | 469,603 | 0.14% | 株式数 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $42,097,461 | 465,371 | 0.14% | 株式数 |
| AVIVA PLC | $41,577,497 | 459,623 | 0.14% | 株式数 |
| Balyasny Asset Management L.P. | $41,248,584 | 455,987 | 0.14% | 株式数 |
| Korea Investment CORP | $40,486,097 | 447,558 | 0.13% | 株式数 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39,585,296 | 437,600 | 0.13% | コールオプション |
| NORDEA INVESTMENT MANAGEMENT AB | $37,761,927 | 418,322 | 0.12% | 株式数 |
| STOREBRAND ASSET MANAGEMENT AS | $37,671,343 | 416,442 | 0.12% | 株式数 |
| Qube Research & Technologies Ltd | $37,490,061 | 414,438 | 0.12% | 株式数 |
| OFI INVEST ASSET MANAGEMENT | $36,480,086 | 458,427 | 0.12% | 株式数 |
| Fisher Funds Management LTD | $35,971,057 | 397,646 | 0.12% | 株式数 |
| LPL Financial LLC | $34,985,891 | 386,755 | 0.12% | 株式数 |
| ABN AMRO INVESTMENT SOLUTIONS | $33,668,217 | 372,189 | 0.11% | 株式数 |
| AMERIPRISE FINANCIAL INC | $32,517,021 | 359,463 | 0.11% | 株式数 |
| BLAIR WILLIAM & CO/IL | $32,206,687 | 356,032 | 0.11% | 株式数 |
| Champlain Investment Partners, LLC | $31,357,054 | 346,640 | 0.10% | 株式数 |
企業インサイダー 48 人のインサイダー · 18人の役員 · 8人の取締役
| インサイダー | 役職 | 最終アクティビティ | 保有株式数 | 12ヶ月購入 | 12ヶ月売却 | 12ヶ月純額 |
|---|---|---|---|---|---|---|
| Bernard J Zovighian | CEO | 2026年7月27日 S | 8,916 | 0 | 8 | $-6,996,971 |
| Theodora Mistras | CVP, Chief Financial Officer | 2026年7月9日 A | 99,920 | 0 | 0 | $0 |
| Thomas M Abate | CVP, CFO | 2013年5月14日 A | 43,047 | 0 | 0 | $0 |
| Wayne Markowitz | CVP, JAPAC | 2026年7月30日 S | 21,534 | 0 | 4 | $-928,942 |
| Annette Bruls | CVP, EMEACLA | 2026年7月11日 F | 20,628 | 0 | 0 | $0 |
| Andrew M. Dahl | SVP, Corporate Controller | 2026年5月29日 S | 15,334 | 0 | 1 | $-48,893 |
| Carlyn D Solomon | CVP, Critical Care & Vascular | 2014年10月28日 M | 31,154 | 0 | 0 | $0 |
| Christine Z Mccauley | CVP, Human Resources | 2013年5月13日 F | 4,035 | 0 | 0 | $0 |
| Paul C Redmond | CVP, Global Operations | 2013年5月13日 S | 12,534 | 0 | 0 | $0 |
| Bruce P Garren | CVP, Public Affairs/Special Co | 2013年5月13日 F | 56,071 | 0 | 0 | $0 |
| John H Kehl JR | CVP, Strategy & Corp Dev | 2013年5月7日 F | 101,767 | 0 | 0 | $0 |
| Robert C Reindl | CVP, H.R. and Communications | 2012年7月27日 M | 1,124 | 0 | 0 | $0 |
| Aimee S Weisner | CVP, General Counsel | 2012年5月9日 A | 1,675 | 0 | 0 | $0 |
| Corinne H Nevinny | CVP & Pres., Global Ops | 2010年5月13日 A | 16,687 | 0 | 0 | $0 |
| Anita Bessler | CVP | 2007年8月31日 S | 29,410 | 0 | 0 | $0 |
| John Alexander Martin | CVP, North America | 2007年5月10日 A | 15,300 | 0 | 0 | $0 |
| Stuart L Foster | CVP, Critical Care / Vascular | 2007年5月10日 A | 24,604 | 0 | 0 | $0 |
| Randel William Woodgrift | Corp VP, Manufacturing Ops | 2005年8月4日 M | 3,349 | 0 | 0 | $0 |
| John T Cardis | 取締役 | 2016年8月10日 S | 91,458 | 0 | 0 | $0 |
| Barbara J Mcneil | 取締役 | 2016年2月4日 S | 46,454 | 0 | 0 | $0 |
| Robert Alexander Ingram | 取締役 | 2015年5月15日 A | 32,367 | 0 | 0 | $0 |
| Michael R Bowlin | 取締役 | 2014年11月14日 M | 81,751 | 0 | 0 | $0 |
| David E I Pyott | 取締役 | 2014年5月9日 A | 53,582 | 0 | 0 | $0 |
| NEAL PHILIP M | 取締役 | 2008年8月12日 M | 27,333 | 0 | 0 | $0 |
| Vernon R Loucks JR | 取締役 | 2008年5月9日 A | 24,133 | 0 | 0 | $0 |
| Daniel J. Lippis | — | 2026年8月11日 M | 40,034 | 0 | 12 | $-817,452 |
| Donald E Bobo JR | — | 2026年5月27日 S | 98,611 | 0 | 12 | $-11,153,294 |
| Daveen Chopra | — | 2026年5月22日 S | 44,324 | 0 | 3 | $-500,535 |
| Scott B. Ullem | — | 2026年5月11日 M | 46,740 | 0 | 7 | $-3,875,008 |
| Leslie C. Davis | — | 2026年5月8日 A | 9,834 | 0 | 0 | $0 |
| Ramona Sequeira | — | 2026年5月8日 A | 6,779 | 0 | 0 | $0 |
| David T Feinberg | — | 2026年5月8日 A | 9,087 | 0 | 0 | $0 |
| Kieran Gallahue | — | 2026年5月8日 A | 4,315 | 0 | 0 | $0 |
| Nicholas J Valeriani | — | 2026年5月8日 A | 84,423 | 0 | 0 | $0 |
| Heisz Leslie Stone | — | 2026年5月8日 A | 34,199 | 0 | 1 | $-218,117 |
| Steven R Loranger | — | 2026年5月8日 A | 8,997 | 0 | 0 | $0 |
| Paul A Laviolette | — | 2026年5月8日 A | 17,552 | 0 | 0 | $0 |
| Larry L Wood | — | 2025年8月18日 M | 206,900 | 0 | 0 | $0 |
| Catherine M. Szyman | — | 2024年9月3日 F | 81,287 | 0 | 0 | $0 |
| Jean-Luc M Lemercier | — | 2024年7月7日 F | 184,686 | 0 | 0 | $0 |
| Robert W.A. Sellers | — | 2024年5月11日 F | 17,081 | 0 | 0 | $0 |
| Michael A Mussallem | — | 2024年5月2日 M | 4,486 | 0 | 0 | $0 |
| Martha H. Marsh | — | 2023年5月12日 A | 31,880 | 0 | 0 | $0 |
| Huimin Wang | — | 2022年7月8日 M | 99,381 | 0 | 0 | $0 |
| William J Link PHD | — | 2020年5月8日 A | 11,349 | 0 | 0 | $0 |
| Wesley W Von Schack | — | 2019年8月1日 S | 8,000 | 0 | 0 | $0 |
| Patrick B Verguet | — | 2017年5月31日 M | 129,137 | 0 | 0 | $0 |
| Randall J Nelson | — | 2003年9月30日 A | — | 0 | 0 | $0 |
SECフォーム3/4/5提出書類からのインサイダー；純額＝公開市場のP/Sのみ
アクティビストおよび5%超のオーナー 1保有
SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図（アクティビストの保有、取締役会キャンペーン、M&A）を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。
| 提出者 | 提出済み | 保有 | ステータス | 目的 | 提出書類 |
|---|---|---|---|---|---|
| 未開示の報告者 | 2001年4月5日 | — | 初回提出 | 取締役会キャンペーン | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF保有状況 180のETFが保有
ウェイトは直接株式保有（N-PORT）のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。
| ファンド | ウェイト | 単位 | 時点 | ソース |
|---|---|---|---|---|
| IHI · iShares Trust | 4.29% | 1,607,851 SH | 2026年8月8日 | 日次 |
| GDOC · Goldman Sachs ETF Trust | 2.98% | 6,939 NS | 2026年5月31日 | N-PORT |
| FMED · Fidelity Covington Trust | 2.11% | 10,000 NS | 2026年5月31日 | N-PORT |
| ANEW · ProShares Trust | 2.02% | 1,801 NS | 2026年5月31日 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 1.83% | 2,435 NS | 2026年4月30日 | N-PORT |
| PJBF · PGIM ETF Trust | 1.75% | 2,374 NS | 2026年5月29日 | N-PORT |
| HRTS · Tema ETF Trust | 1.75% | 10,488 NS | 2026年5月31日 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.58% | 137,940 SH | 2026年8月8日 | 日次 |
| VOT · VANGUARD INDEX FUNDS | 1.14% | 4,411,246 SH | 2026年8月8日 | 日次 |
| ALTL · Pacer Funds Trust | 0.94% | 10,780 NS | 2026年4月30日 | N-PORT |
| CVAR · ETF Opportunities Trust | 0.93% | 4,325 NS | 2026年4月30日 | N-PORT |
| SDG · iShares Trust | 0.90% | 17,447 SH | 2026年8月8日 | 日次 |
| FFND · Northern Lights Fund Trust II | 0.88% | 10,459 NS | 2026年5月31日 | N-PORT |
| IYH · iShares Trust | 0.83% | 341,366 SH | 2026年8月8日 | 日次 |
| BKDV · BNY Mellon ETF Trust II | 0.81% | 134,666 NS | 2026年4月30日 | N-PORT |
| NULV · Nushares ETF Trust | 0.79% | 197,378 NS | 2026年4月30日 | N-PORT |
| JOET · Virtus ETF Trust II | 0.79% | 22,410 NS | 2026年4月30日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.78% | 267,514 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.77% | 1,733,147 SH | 2026年8月8日 | 日次 |
| NULC · Nushares ETF Trust | 0.75% | 5,090 NS | 2026年4月30日 | N-PORT |
| RXL · ProShares Trust | 0.73% | 6,052 NS | 2026年5月31日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.70% | 11,571 NS | 2026年4月30日 | N-PORT |
| IMCG · iShares Trust | 0.66% | 301,692 SH | 2026年8月8日 | 日次 |
| IXJ · iShares Trust | 0.65% | 302,050 SH | 2026年8月8日 | 日次 |
| TEC · Harbor ETF Trust | 0.61% | 491 NS | 2026年4月30日 | N-PORT |
| FWD · AB Active ETFs, Inc. | 0.56% | 187,544 NS | 2026年5月31日 | N-PORT |
| HUSV · First Trust Exchange-Traded Fund III | 0.56% | 4,857 NS | 2026年4月30日 | N-PORT |
| BRNY · EA Series Trust | 0.54% | 35,555 NS | 2026年4月30日 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.53% | 24,654 NS | 2026年5月31日 | N-PORT |
| SUSA · iShares Trust | 0.51% | 237,552 SH | 2026年8月8日 | 日次 |
| VO · VANGUARD INDEX FUNDS | 0.50% | 12,477,902 SH | 2026年8月8日 | 日次 |
| IWS · iShares Trust | 0.49% | 860,071 SH | 2026年8月8日 | 日次 |
| FXH · First Trust Exchange-Traded AlphaDE… | 0.42% | 44,305 NS | 2026年4月30日 | N-PORT |
| HELO · J.P. Morgan Exchange-Traded Fund Tr… | 0.40% | 193,493 NS | 2026年4月30日 | N-PORT |
| JOYT · J.P. Morgan Exchange-Traded Fund Tr… | 0.37% | 3,768 NS | 2026年4月30日 | N-PORT |
| IWR · iShares Trust | 0.36% | 2,320,860 SH | 2026年8月8日 | 日次 |
| IMCB · iShares Trust | 0.34% | 63,843 SH | 2026年8月8日 | 日次 |
| JGLO · J.P. Morgan Exchange-Traded Fund Tr… | 0.34% | 286,558 NS | 2026年4月30日 | N-PORT |
| EVUS · iShares Trust | 0.31% | 12,935 SH | 2026年8月8日 | 日次 |
| NBCR · Neuberger Berman ETF Trust | 0.30% | 30,404 NS | 2026年5月31日 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.29% | 156,342 SH | 2026年8月8日 | 日次 |
| XOEF · iShares Trust | 0.28% | 720 SH | 2026年8月8日 | 日次 |
| ESUM · Strategy Shares | 0.27% | 5,033 NS | 2026年4月30日 | N-PORT |
| DFLV · Dimensional ETF Trust | 0.27% | 189,108 NS | 2026年4月30日 | N-PORT |
| WINN · Harbor ETF Trust | 0.24% | 31,226 NS | 2026年4月30日 | N-PORT |
| DEUS · DBX ETF Trust | 0.24% | 7,428 NS | 2026年5月29日 | N-PORT |
| HEQQ · J.P. Morgan Exchange-Traded Fund Tr… | 0.23% | 887 NS | 2026年4月30日 | N-PORT |
| FFLG · FIDELITY COVINGTON TRUST | 0.22% | 15,544 NS | 2026年4月30日 | N-PORT |
| CAPE · DoubleLine ETF Trust | 0.22% | 7,122 NS | 2026年3月31日 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0.21% | 42,168 NS | 2026年5月31日 | N-PORT |